HOPKINS ROBERT O (Chief Financial Officer) sold 12.1% of their position (35K shares) of DMK PHARMACEUTICALS CORP on the open market
Open‑market sale worth $14.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/24/2020ACC: 0001593968-20-002245
Officer· Chief Financial Officer
Since Jan 2019
-35K
Net shares
Net seller
$14.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
35K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−35K
Price / share
$0.41
Trade value
$14.18K
% of position
12.1%
11/20/2020
289.81K→254.81K
Total
Net shares
−35K
Net value
-$14.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2020 | S · Sale | −35K | $0.41 | $14.18K | 12.1% | 289.81K | 254.81K |
| Total | −35K | -$14.18K | ||||||
Derivative Transactions0
No derivative transactions reported